Improving Patient Safety & Care Webinar Series

Maternal Mortality

During Covid19  

TBC August 2020

13:00 - GMT

Register Now

Proposed Presenters


A Representative

To be Confirmed
NHS England & Improvement

TBC 1.jpeg

Industry Partner

To be Confirmed

Monitoring reliably and consistently the health of babies during childbirth remains a massive unmet clinical need worldwide. Hypoxic-ischaemic encephalopathy (HIE) continues to be an important cause of stillbirth, neonatal encephalopathy, and neonatal mortality, both in high and low-resource countries. Intrapartum-related events are estimated to account for nearly a quarter of neonatal deaths and are second only to prematurity as a cause of neonatal mortality. HIE is estimated to account for 920,000 neonatal deaths every year and is associated with another 1.1 million intrapartum stillbirths. Moreover, those who survive (more than a million per year) develop different important sequelae, from cerebral palsy to mental retardation, learning difficulties and other disabilities. 


More than 200 million pregnant women around the world are potentially at risk since the outbreak of COVID-19. Studies are only beginning to shed light on the degree of danger that pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents to them and their newborns. The initial data seem cautiously reassuring, but researchers around the world are racing to collect data that should provide more definitive answers.

There is a clear need for close multidisciplinary collaboration, for the creation of new, curated datasets, and particularly close collaboration between computing/data science and clinical experts. 

This webinar is looking for high impact research (Perspectives, Reviews, Case Studies, Research Articles) from contributors around the world that can help us create an updated view of the current challenges, recent achievements, and next steps to advance in our quest to create new bedside technologies which help clinicians to deliver healthy babies. As highly relevant, we also welcome insights from maternal-fetal data in the antepartum period as well as neurological development in children from birth on and long past the first years of life.